This peer-reviewed study, accepted to the 2026 Proceedings of Artificial Intelligence in Medicine (AIME), introduces a voice-based clinical decision support […]
Read moreThis peer-reviewed study, accepted to the 2026 Proceedings of Artificial Intelligence in Medicine (AIME), introduces a voice-based clinical decision support […]
Read moreThis study, conducted by researchers from Beth Israel Deaconess Medical Center, University of California San Diego School of Medicine, Harvard […]
Read moreThis research white paper highlights the potential of vocal biomarkers as a scalable, non-invasive tool for detecting anxiety and depression, […]
Read moreThis study, conducted in collaboration with Beth Israel Deaconess Medical Center and the University of Massachusetts Chan Medical School, introduces […]
Read moreNew research, co-authored by Canary Speech and Japan’s National Cerebral and Cardiovascular Center (NCVC) scientists and published in The Lancet Regional Health […]
Read moreAbstract: Mild Cognitive Impairment (MCI) is a condition where an individual’s ability to perform regular activities starts deteriorating. It is […]
Read moreCall centers are under immense pressure from within and without. Internally, they face one of the industry’s most persistent and […]
Read moreIdentifying and addressing mild cognitive impairment (MCI) and other neurological conditions is difficult, subjective, and costly. In a partnership with […]
Read moreThis study focuses on mental healthcare, specifically on the detection of anxiety and depression. We present a comparison of results […]
Read moreHuntington’s disease (HD) is an autosomal-dominant neurode-generative disorder that leads to the devastating loss of motor control – including severe […]
Read moreSchedule a demo with us to learn how Canary's patented vocal biomarker platform works. Explore assessments and screening to see how Canary analyzes and tracks the presence and severity of targeted illnesses.